Effect of Carvedilol on Survival in Severe Chronic Heart Failure
New England Journal of MedicinePublished 31 May 2001Open access
Milton Packer, Andrew J.S. Coats, Michael B. Fowler, Hugo A. Katus, Henry Krum, Paul Mohaçsi
Citations3,074
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also apparent in the patients with severe heart failure who were evaluated in this trial.
Keywords
Medicine
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
New England Journal of MedicineThe Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
8,985 Citations1999Bertram Pitt, Faı̈ez Zannad +6 more
Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
New England Journal of MedicineEffect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
8,006 Citations1991The SOLVD Investigators*
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
7,727 Citations1958Edward L. Kaplan, Paul Meier
The LancetEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
5,122 Citations1999
Metoprolol controlled release/extended release (CR/XL) once daily in addition to standard therapy improved survival and the drug was well tolerated.
New England Journal of MedicineEffects of Enalapril on Mortality in Severe Congestive Heart Failure
5,077 Citations1987The Consensus Trial Study Group*
It is concluded that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms and a significant improvement in NYHA classification was observed in the enAlapril group.
The LancetThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
4,913 Citations1999Lechat, P, Brunhuber, Kw +280 more
Beta-blocker therapy had benefits for survival in stable heart-failure patients and should not be extrapolated to patients with severe class IV symptoms and recent instability because safety and efficacy has not been established in these patients.
New England Journal of MedicineThe Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
4,656 Citations1996Milton Packer, Michael R. Bristow +5 more
Carvedilol reduces the risk or death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor.
BiometricsA Multiple Testing Procedure for Clinical Trials
3,349 Citations1979Peter C. O’Brien, Thomas R. Fleming
The overall size of the procedure is shown to be controlled with virtually the same accuracy as the single sample chi-square test based on N(m1 + m2) observations and the power is found to bevirtually the same.
JAMAEffects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure
1,382 Citations2000Åke Hjalmarson, Sidney Goldstein +22 more
In this study of patients with symptomatic heartfailure, metoprolol CR/XL improved survival, reduced the need for hospitalizations due to worsening heart failure, improved NYHA functional class, and had beneficial effects on patient well-being.
New England Journal of MedicineEffect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
1,183 Citations1996Milton Packer, Christopher M. O’Connor +10 more
A new calcium-channel blocker, amlodipine, did not increase cardiovascular morbidity or mortality in patients with severe chronic heart failure and the possibility that amlidipine prolongs survival in Patients with nonischemic dilated cardiomyopathy requires further study.
Journal of the American College of CardiologyIncreased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
558 Citations1998Mary Keith, Amir Geranmayegan +5 more
A progressive increase in free radical injury and encroachment on antioxidant reserves with the evolution of heart failure is demonstrated and oxidative stress may be an important determinant of prognosis; the therapeutic benefit of administering antioxidant supplements to patients with CHF should be evaluated.
CirculationLong-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
447 Citations1989Finn Waagstein, Kenneth Caidahl +3 more
Patients with dilated cardiomyopathy had a low number of ventricular beta-adrenergic receptors compared with healthy control subjects, but long-term treatment with metoprolol caused a moderate up-regulation, which may facilitate a more normal response to sympathetic stimulation.
Journal of the American College of CardiologyPrognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
344 Citations1996Richard Pacher, Brigitte Stanek +9 more
In advanced heart failure, plasma big endothelin-1 is strongly related to survival and appears to predict 1-year mortality better than hemodynamic variables and levels of atrial natriuretic peptide, an established neurohumoral prognostic marker in chronic heart failure.
The American Journal of MedicineImportance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure
214 Citations1963Thomas E. Gaffney, Eugene Braunwald
It is suggested that the adrenergic nervous system plays an important compensatory role in the circulatory adjustments of patients to congestive heart failure, and the need for caution in the use of highly effective antiadrenergic drugs in the treatment of patients with limited cardiac reserve is emphasized.
CirculationCarvedilol Inhibits Reactive Oxygen Species Generation by Leukocytes and Oxidative Damage to Amino Acids
141 Citations2000Paresh Dandona, Rajaram Karne +4 more
It is concluded that carvedilol significantly inhibits ROS generation by leukocytes and oxidative conversion of phenylalanine to m- and o-tyrosine and antioxidant effect in humans in vivo.
CirculationEndothelin-1 Is Involved in Norepinephrine-Induced Ventricular Hypertrophy In Vivo
140 Citations1996Samer Kaddoura, John D. Firth +3 more
Analysis of the effects of continuous norepinephrine infusion on physical and molecular markers of ventricular hypertrophy, ventricular and noncardiac expression of ET-1 mRNA, and the acute effects of bosentan suggests that endogenousET-1 plays a direct role in mediating nore Pinephrine-induced ventricularhypertrophy in vivo.
Progress in Cardiovascular Diseasesβ-adrenergic blockade in chronic heart failure: Principles, progress, and practice
99 Citations1998Milton Packer
This hypothesis is now being evaluated in a large-scale, long-term, international trial, which aims to establish whether agents that block alpha1-, betal-, and beta2-receptors be more effective and better tolerated that agents that act selectively on the beta1-receptor.
Journal of Cardiovascular PharmacologyMechanism of Action of Bucindolol in Human Ventricular Myocardium
75 Citations1990Ray E. Hershberger, John R. Wynn +2 more
Although bucindolol has measurable intrinsic sympathomimetic activity (ISA) in some animal systems, no increase in adenylate cyclase activity or muscle contraction was detected in preparations of human heart.
Cardiovascular ResearchAltered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy
57 Citations1998Makoto Suzuki
After CHF, ET-1 produces a direct depression of cardiomyocyte contractile performance that is associated with a significant decrease in the peak [Ca2+]i transient, which is likely to be mediated through ETA receptors and involve the PKC pathway.
Journal of Molecular and Cellular CardiologyCarvedilol Inhibits Endothelin-1 Biosynthesis in Cultured Human Coronary Artery Endothelial Cells
51 Citations1998Eliot H. Ohlstein, Anthony J. Arleth +2 more
It is demonstrated that carvedilol directly inhibits the biosynthesis of ET-1 in HCAECs, and this effect may contribute to its vasodilating and antiproliferative actions.
Circulation ResearchContribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy.
40 Citations1983S. E. Downing, J C Lee
It is concluded that norepinephrine cardiomyopathy results in large part from activation of the α-adrenergic system in the rabbit model and alterations in myofiber Ca++ translocation, uptake, and binding induced by ai-receptor activation may contribute to membrane damage.
Journal of Pharmacology and Experimental TherapeuticsIn Vitro and In Vivo Characterization of Intrinsic Sympathomimetic Activity in Normal and Heart Failure Rats
32 Citations1999Robert N. Willette, Nambi Aiyar +8 more
The American Journal of CardiologyMeta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure
28 Citations2000Sarah L. Whorlow, Henry Krum